10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
15.70
-0.19 (-1.20%)
Nov 17, 2025, 4:00 PM EST - Market closed
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.99 billion as of November 17, 2025. Its market cap has decreased by -0.53% in one year.
Market Cap
1.99B
Enterprise Value
1.62B
1-Year Change
-0.53%
Ranking
Category
Stock Price
$15.70
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.99B, a decrease of -59.89%. That is a compound annual growth rate of -13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 2.01B | 15.68% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 917.54B |
| Johnson & Johnson | 480.03B |
| AbbVie | 413.09B |
| UnitedHealth Group | 292.69B |
| AstraZeneca | 276.16B |
| Novartis AG | 255.14B |
| Merck & Co. | 232.84B |
| Abbott Laboratories | 228.28B |